Interview: Gaby Murphy – Managing Director, EMD Serono, Canada
At the 350th anniversary of the company, Gaby Murphy, EMD Serono’s managing director, gives an insight into the turning point for the affiliate in 2017 with three new Health Canada…
Striving to transform lives through medical science
EMD Serono, Canada, provides innovative drug therapies that address unmet medical needs in the areas of neurodegenerative diseases, fertility and endocrinology.
EMD Serono, Canada, helps people better understand and manage their disease through relevant and user-friendly education resources and a dedicated patient support team.
EMD Serono, Canada, is founded upon the proud heritage of Merck KGaA, Germany. In the United States and Canada, the division operates as EMD Serono.
To learn more about the company’s business outside of Canada, please visit the Merck Group website.
http://www.emdserono.ca/en/index.html
EMD Serono, Canada
2695 North Sheridan Way, Suite 200
Mississauga, ON L5K 2N6
Tel: 905-919-0200 or 1-888-737-6668
Fax: 905-919-0299
At the 350th anniversary of the company, Gaby Murphy, EMD Serono’s managing director, gives an insight into the turning point for the affiliate in 2017 with three new Health Canada…
Investissement Québec (IQ) contributed to the completion of 65 international projects in 2017 and hosts Pfizer, Sanofi, and Merck amongst over 160 IT companies, employing over 5,400 workers. Pierre Gabriel…
Imran Ali, senior manager of the pan-Canadian Pharmaceutical Alliance (pCPA) Office, the body that provides dedicated centralized support to the national negotiating process for drug prices, representing all 14 public…
Taiho Pharmaceutical Co., Ltd. (TPC), Japan, part of Otsuka Holdings, established its Canadian affiliate in 2017. Ross Glover, general manager for Taiho Pharma Canada, has spent the past year tackling…
At the company’s 40th anniversary, Biogen’s Canadian head Marina Vasiliou gives an insight into her priorities as new managing director, her approach to building relationships with all stakeholders in the…
Looking back on his first year as CEO of Organigram, Greg Engel proudly highlights the successful transition of the company from being a low-cost to a high-quality cannabis producer with…
Still in the process of integration, Mallinckrodt is preparing to build its launch structure in Canada. With several innovative products in the pipeline, Robin Hunter, general manager of Canadian operations,…
Boston Scientific’s vice president and general manager Ken Spears shares his thoughts about the potential for Canada to become an early adopter of innovation and to move towards an outcome-based…
Hydropothecary is the leading medicinal cannabis producer in Quebec, founded in 2013 by two brothers-in-law, Sebastien St-Louis and Adam Miron. Terry Lake, former Minister of Health for British Colombia, discusses…
Upon opening an R&D center in Mississauga in 2017, Biolab Pharma Canada, headed by Paulo Wickbold Marques, became the first Brazilian pharmaceutical company to establish an affiliate in Canada. In…
Halo Pharma, a US-based one-stop-shop CDMO (Contract Development and Manufacturing Organization), operates out of a site in Mirabel, close to Montreal, that boasts 30 years of experience in developing and…
Boiron Canada is the sixth largest affiliate of Boiron’s global operations (in terms of sales), and under Daniel Dereser’s leadership, the company intends to change the perception of homeopathic medicine…
See our Cookie Privacy Policy Here